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The Leak Goes On*Blase A. Carabello, MD,* John D. Puskas, MDyT ranscatheter aortic valve replacement(TAVR) has rapidly become a mainstay inthe treatment of high-risk and extremely
high-risk patients with aortic stenosis (AS). The pro-
cedure improves survival compared with conserva-
tive therapy and is equivalent to or even superior to
surgical aortic valve replacement (SAVR) in patients
at high operative risk (1,2). However, despite the
remarkable beneﬁts of TAVR, the design of present
TAVR prostheses and the methods of their delivery
often lead to post-procedure aortic regurgitation
(AR) not usually seen after SAVR. Critically, post-
procedure AR is associated with both increased early
and late post-TAVR mortality (3–7).
Although the association of AR and increased
post-TAVR mortality has been known for some time,
the study by Jerez-Valero et al. (8), in this issue of
JACC: Cardiovascular Interventions, adds measurably
to our understanding of this entity by adding an
additional 1,735 patients to our collective data base.
They clarify that it is primarily acute, moderate to
severe post-TAVR AR that has the most impact on
mortality.SEE PAGE 1022Two reasonable types of hypotheses may explain
the relationship of AR to TAVR outcome: procedural
and hemodynamic. Our procedural hypothesis is that
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the contents of this paper to disclose.experience of the operators performing the proce-
dure. In this scenario, operator inexperience affects
procedure outcome, and AR is a marker of that inex-
perience. As such, AR itself is a variable unrelated to
outcome but rather a marker of skill sets. In support
of this hypothesis are previous data suggesting that
even mild AR had an adverse effect on outcome
(5,9), an unlikely result of the minimal hemodynamic
adversity imposed by mild post-TAVR AR. The cur-
rent study reduces the plausibility of this hypothesis
on 2 counts. First, the operators reporting in this
study are highly experienced, and although we do
not know the time frame of the incidence of the AR
(early or late in their experience), the large number
of patients would put the vast majority beyond the
operators’ learning curves. Additionally this large
study suggests that mild AR does not affect mortal-
ity; it seems likely that the negative impact of
moderate to severe post-TAVR AR on survival is
based on adverse hemodynamics imposed by volume
overload.
ACUTE AR AND THE PREVIOUSLY
NORMAL LEFT VENTRICLE
In chronic AR, left ventricular (LV) eccentric
remodeling and hypertrophy compensate for the
stroke volume lost to regurgitation, allowing the
left ventricle to maintain a nearly normal cardiac
output while accommodating the volume overload
at tolerable ﬁlling pressures (10). This adaptation
allows the patient with severe AR to be free of
symptoms, even during fairly strenuous activity.
However, in acute severe AR, adaptive remodeling
has not yet occurred. Thus, forward stroke volume
is diminished and rapid LV ﬁlling from the AR
together with a rapid decrease in aortic pressure
causes early equalization of LV and distal diastolic
pressures (Figure 1) (11), at which point subendocardial
FIGURE 1 Left Ventricular and Femoral Artery Pressure Tracings From a
Patient With Severe Acute Aortic Regurgitation
Femoral and left ventricular pressures become equal in mid-diastole.
Reprinted with permission from Carabello and Gazes (11).
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1034coronary blood ﬂow must cease. The outcome of
severe acute AR untreated with aortic valve replace-
ment is poor, almost surely due to these adverse he-
modynamics. Importantly, in the current study, it was
acute AR, not chronic AR (deﬁned as AR that existed
before TAVR), that had negative impact on survival.FIGURE 2 Pressure-Volume Data From an AS Patient Are
Shown Before AS and After Aortic Valve Replacement
Complicated by Acute AI
Aw15% increase in end-diastolic volume increases end-diastolic
pressure by nearly 100%. AI ¼ aortic insufﬁciency; AS ¼ aortic
stenosis; LV ¼ left ventricular. Reprinted with permission from
Gaash et al. (12).ACUTE AR AND THE PREVIOUSLY PRESSURE
OVERLOADED LEFT VENTRICLE
Although acute AR after TAVR is rarely as severe as in
the patient’s hemodynamics portrayed in Figure 1, it
does not have to be to impart serious hemodynamic
impairment. Obviously TAVR is performed in patients
with severe AS. This long-standing pressure overload
results in concentric LV hypertrophy, reducing LV
compliance and causing increased LV diastolic pres-
sure for any given LV diastolic volume. The pressure-
volume data (Figure 2) obtained by Gaasch et al. (12)
are instructive in this regard. By serendipity,
pressure-volume data were obtained from a patient
with severe AS in whom postoperative AR subse-
quently developed. The ﬁgure demonstrates that as
little as 15 ml of additional LV diastolic volume led to
LV ﬁlling pressures high enough to cause pulmonary
edema at rest. Thus, even moderate acute post-TAVR
AR would be expected to have signiﬁcantly negative
hemodynamic consequences, likely affecting sur-
vival. Further, the additional volume overload in the
current study modestly impaired improvement in
mitral regurgitation (MR), presumably because the
volume overload from AR prevented reverse eccentric
remodeling and reduction of functional MR. Persis-
tent MR may also have affected survival.
UNRESOLVED ISSUES
Although it seems clear that signiﬁcant AR after TAVR
negatively affects prognosis, areas of uncertainty still
exist. First. assessment of AR in most centers is
qualitative or semiquantitative, at best. Thus, exactly
how much additional diastolic volume is added is
usually unknown. Further, each patient is different
and as such has different LV compliance. It is likely
that 15 ml of regurgitant volume may cause hemo-
dynamic embarrassment in 1 patient’s stiff left
ventricle but not in another patient with a more
compliant ventricle. Thus, measurement of not only
the amount of AR but also its effect on hemodynamics
would be a better indicator of need to mechanically
address post-TAVR AR. Second, post-deployment
dilation has risks of its own, including annular
rupture and possibly increased incidence of peri-
procedural stroke. When the beneﬁt of the correction
of AR outweighs these risks is as yet unknown. These
issues may become moot in the relatively near future
as newer valves are engineered to avoid post-
deployment AR.
Post-TAVR aortic regurgitation reduces prog-
nosis, almost certainly because of the adverse he-
modynamics it imposes. Engineering the design of
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1035next-generation prostheses to prevent AR will be
crucial to enhancing TAVR outcomes in the future.
Meanwhile, improved understanding of when to
address post-TAVR AR with additional manipulation
will help Heart Team operators optimize outcomes for
our shared patients.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
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